NCT00609765 Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Status TERMINATED Phase PHASE2
NCT00609518 A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00609167 Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00608101 Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus Status WITHDRAWN Phase NA
NCT00607581 Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis Status COMPLETED Phase PHASE2
NCT00603447 Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00601172 A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. Status COMPLETED Phase PHASE3
NCT00598169 Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT00581776 Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00580112 An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00579501 Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma Status COMPLETED Phase PHASE2
NCT00572169 UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00564889 Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Status COMPLETED Phase PHASE2
NCT00564200 MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning Status COMPLETED Phase PHASE2
NCT00562965 Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL) Status TERMINATED Phase PHASE3
NCT00560352 Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma Status TERMINATED Phase PHASE1
NCT00559481 Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy Status WITHDRAWN Phase NA